Skip to main content

Advertisement

SpringerLink
Log in

Targeting interleukin-21 in rheumatoid arthritis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Interleukin-21 (IL-21) is a new member of the type I cytokine superfamily, which binds to a composite receptor that consists of a private receptor (IL-21R) and the common cytokine receptor γ chain. Recently, increasing evidence has shown that IL-21 contributes to the pathogenesis of chronic inflammatory and autoimmune diseases because of its pro-inflammatory and immune-mediated properties. IL-21 induced T-cell activation and pro-inflammatory cytokine secretion in rheumatoid arthritis (RA). IL-21R RNA transcripts were found in synovial tissue samples of patients with RA. In addition, blockade of the IL-21/IL-21R pathway ameliorated disease in animal models of RA and significantly inhibited inflammatory cytokine production in vitro. Moreover, IL-21R deficiency in the K/BxN mouse model of inflammatory arthritis was sufficient to block arthritis initiation completely. All theses findings suggest that IL-21 has important biological effects in autoimmunity that might be a promising therapeutic target for RA. In this review, we discuss the biological features of IL-21 and summarize recent advances in the role of IL-21 in the pathogenesis and treatment of RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ji JD, Lee WJ, Kong KA et al (2010) Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 37:141–147

    Article  CAS  PubMed  Google Scholar 

  2. Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594–1602

    Article  CAS  PubMed  Google Scholar 

  3. Kay J, Calabrese L (2004) The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxf) 43(Suppl 3):iii2–iii9

    Article  Google Scholar 

  4. Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740–1751

    Article  CAS  PubMed  Google Scholar 

  5. Gomez-Reino JJ, Carmona L, Valverde VR et al (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127

    Article  CAS  PubMed  Google Scholar 

  6. Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888–898

    Article  CAS  PubMed  Google Scholar 

  7. Jungel A, Distler JH, Kurowska-Stolarska M et al (2004) Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 50:1468–1476

    Article  PubMed  Google Scholar 

  8. Monteleone G, Pallone F, Macdonald TT (2009) Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends Pharmacol Sci 30:441–447

    Article  CAS  PubMed  Google Scholar 

  9. Parrish-Novak J, Dillon SR, Nelson A et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57–63

    Article  CAS  PubMed  Google Scholar 

  10. Jang E, Cho SH, Park H et al (2009) A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25− T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J Immunol 182:4649–4656

    Article  CAS  PubMed  Google Scholar 

  11. Spolski R, Leonard WJ (2008) The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 20:295–301

    Article  CAS  PubMed  Google Scholar 

  12. Hiromura Y, Kishida T, Nakano H et al (2007) IL-21 administration into the nostril alleviates murine allergic rhinitis. J Immunol 179:7157–7165

    CAS  PubMed  Google Scholar 

  13. Ettinger R, Kuchen S, Lipsky PE (2008) Interleukin 21 as a target of intervention in autoimmune disease. Ann Rheum Dis 67(Suppl 3):iii83–iii86

    Article  CAS  PubMed  Google Scholar 

  14. Young DA, Hegen M, Ma HL et al (2007) Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 56:1152–1163

    Article  CAS  PubMed  Google Scholar 

  15. Parrish-Novak J, Foster DC, Holly RD et al (2002) Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leukoc Biol 72:856–863

    CAS  PubMed  Google Scholar 

  16. Brandt K, Bulfone-Paus S, Foster DC et al (2003) Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102:4090–4098

    Article  CAS  PubMed  Google Scholar 

  17. Douagi I, Colucci F, Di Santo JP et al (2002) Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver. Blood 99:463–471

    Article  CAS  PubMed  Google Scholar 

  18. Caruso R, Fina D, Peluso I et al (2007) IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J Immunol 178:5957–5965

    CAS  PubMed  Google Scholar 

  19. Andorsky DJ, Timmerman JM (2008) Interleukin-21: biology and application to cancer therapy. Expert Opin Biol Ther 8:1295–1307

    Article  CAS  PubMed  Google Scholar 

  20. Mehta DS, Wurster AL, Grusby MJ (2004) Biology of IL-21 and the IL-21 receptor. Immunol Rev 202:84–95

    Article  CAS  PubMed  Google Scholar 

  21. Collins M, Whitters MJ, Young DA (2003) IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity. Immunol Res 28:131–140

    Article  CAS  PubMed  Google Scholar 

  22. Mizuguchi M, Asao H, Hara T et al (2009) Transcriptional activation of the interleukin-21 and its receptor genes by human T-cell leukemia virus type 1 tax in human T-cells. J Biol Chem 284:25501–25511

    Article  CAS  PubMed  Google Scholar 

  23. Habib T, Nelson A, Kaushansky K (2003) IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J Allergy Clin Immunol 112:1033–1045

    Article  CAS  PubMed  Google Scholar 

  24. Habib T, Senadheera S, Weinberg K et al (2002) The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41:8725–8731

    Article  CAS  PubMed  Google Scholar 

  25. Brandt K, Singh PB, Bulfone-Paus S et al (2007) Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 18:223–232

    Article  CAS  PubMed  Google Scholar 

  26. Ozaki K, Kikly K, Michalovich D et al (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 97:11439–11444

    Article  CAS  PubMed  Google Scholar 

  27. Strengell M, Matikainen S, Siren J et al (2003) IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 170:5464–5469

    CAS  PubMed  Google Scholar 

  28. Feldmann M, Maini SR (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223:7–19

    Article  CAS  PubMed  Google Scholar 

  29. Li J, Shen W, Kong K et al (2006) Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 64:515–522

    Article  CAS  PubMed  Google Scholar 

  30. Davis ID, Skak K, Smyth MJ et al (2007) Interleukin-21 signaling: functions in cancer and autoimmunity. Clin Cancer Res 13:6926–6932

    Article  CAS  PubMed  Google Scholar 

  31. Sarkar S, Fox DA (2010) Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum Dis Clin N Am 36:345–366

    Article  Google Scholar 

  32. Li X, Yuan FL, Lu WG et al (2010) The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 397:131–135

    Article  CAS  PubMed  Google Scholar 

  33. Niu X, He D, Zhang X et al (2010) IL-21 regulates Th17 cells in rheumatoid arthritis. Hum Immunol 71:334–341

    Article  CAS  PubMed  Google Scholar 

  34. Andersson AK, Feldmann M, Brennan FM (2008) Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Scand J Immunol 68:103–111

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the China National Science Foundation grants no. 30901526 and no. 30873080.

Author information

Authors and Affiliations

  1. The Third Hospital Affiliated to Nantong University, Wuxi, 214041, Jiangsu, People’s Republic of China

    Feng-Lai Yuan, Wei-Guo Lu, Xia Li, Jian-Ping Li, Rui-Sheng Xu, Cheng-Wan Li & Cheng Jin

  2. Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, People’s Republic of China

    Wei Hu

  3. College of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, People’s Republic of China

    Fei-Hu Chen

Authors
  1. Feng-Lai Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-Guo Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian-Ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rui-Sheng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cheng-Wan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fei-Hu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cheng Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei-Guo Lu or Fei-Hu Chen.

Additional information

Feng-Lai Yuan, Wei-Hu are the authors contributed equally to this work and should be considered co-first authors.

Wei-Guo Lu, Fei-Hu Chen are the authors contributed equally to this work and should be considered co-corresponding author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuan, FL., Hu, W., Lu, WG. et al. Targeting interleukin-21 in rheumatoid arthritis. Mol Biol Rep 38, 1717–1721 (2011). https://doi.org/10.1007/s11033-010-0285-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0285-x

Keywords

Search

Navigation